Tentative Program

conferenceseries.com

Cancer Science 2017

Tentative Program 19th Euro Congress on

Cancer Science and Therapy Lisbon, Portugal

July 17-19, 2017

Exhibitor

Interactive Sessions

Keynote Lectures Exhibitors

***For

Plenary Lectures

Workshops

B2B

Meetings

available speaker slots***

[email protected] cancerscience.conferenceseries.com

conferenceseries.com

Cancer Science 2017

Tentative Scientific Program KEYNOTE FORUM Title : The Natural History of Breast Cancers Alvaro Macieira-Coelho French National Institute of Health (INSERM), France Title : Breast Cancer and Personalized Medicine: Advances, Conundrums and Novel Therapeutic Interventions Sherry A. Bradford AccuTheranostics, Inc. , USA Title : Antitumoral Hormonal Therpay : Effects on the Uterus Liane Deligdisch Mount Sinai School of Medicine, USA ***5 Keynote Speaker Slots Available *** ***Speaker Presentations***

Title : CpG Simulated Karyotypic Analysis of Chronic Lymphocytic Leukemia (CLL) Is a Significant Prognostic Factor and Should Be Performed on all Patients Nyla Heerema The Ohio State University Wexner Medical Center, USA Title : Evolution of a “System” for Surgical Treatment of Adenocarcinomas Charles Hitchcock The Ohio State University, USA Title : Creating the best clinical and economic evidence to assist decision-making in urological cancers Alice Dragomir

McGill University ,Canada

***Workshop*** Dr. Lloyd Jenkins, Budwig Center, Spain Title : ARF proteins as new molecular targets for the treatment of invasive breast cancer Audrey Claing Université de Montréal, Canada Title : Combining Multi-parametric MRI (mpMRI), MR-Ultrasound Fusion Biopsy, and High Intensity Focused Ultrasound (HIFU): A Winning Team in the Fight Against Organ Confined Prostate Cancer Les Bentz Vituro Health, USA Title : Communication network mediated by exosomes as a new therapeutic target for pancreatic cancer Sonia A Melo University of Porto,Portugal Title : Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs Guanlin Wang Kunming University of Science and Technology, China Title : Effects of Clinical Pilates Exercises on Patients Developing Lymphedema after Breast Cancer Treatment Hulya Ozlem Sener

Fisioterapia Consultancy of Exercise Training, IZMIR - Turkey

Title : Using “Zero-ischemia” and “Sutureless” Techniques to Implement Laparoscopic Partial Nephrectomy with Holmium Laser Qi-Fei Wang

The First Affiliated Hospital of Dalian Medical University, CHINA Title : Supportive Care : The Patient's Care Louis Caze Center Louis Caz, France

cancerscience.conferenceseries.com

Title : Evaluation of early treatment response using dynamic MRI of Drug-Eluting Beads Transarterial Chemoembolization for hepatocellular carcinoma Kuniaki Arai Kanazawa University Hospital, Japan Title : FolamiRs: Ligand-targeted, vehicle-free microRNA replacement therapy Andrea Kasinski Purdue University, USA Title : Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary dysfunction Fouad Azizi Hamad Medical Corporation (HMC), Qatar Title : A prospective study on chemotherapy induced anaemia in cancer patients undergoing treatment using serisl haemoglobin easurement at the National hospital Abuja, Nigeria Simeon Chinedu National Hospital Abuja, Nigeria

Title : Obesity as a prognostic feature in breast cancer Hojouj Mohammad Dnipropetrovsk medical academy of Health Ministry of Ukraine, Ukraine Title : Oncoloytic Efeebt of newcastle disease virus in treatment of Breast Cancer Ahmed Alharery Mansoura University, Eqypt Title : Reactive Oxygen Species promote doxorubicin-induced P-gp expression in colon cancer cells Martha Pinzon-Daza, Universidad del Rosario, Colombia

Universidad del Rosario, Bogotá-Colombia Title : Transition metal complexes/organometallic compounds as anticancer/anti HIV drugs or in pharmaceutical industry Prakash Kinthada JNTU University, India

Speaker Slots Available Title : Protein expression profiling of sorafenib-resistant human renal cancer stem-like cells in three-dimensional in vitro model Zofia Felicja Bielecka Warsaw Medical University, Poland

Title : Membranous Expression of panCD66, CD66 a, CD66 b, and CD66 c and Their Clinical Impact in Acute Leukaemia

Nahla Ibrahim Cairo University, Egypt

Title : Investigation of LRRC24, a putative negative regulator of ErbB receptor tyrosine kinases Amber Andrews Hampton University, USA Title : Topology, Trafficking and Membrane Orientation of Cancer-Oocyte Neoantigen SAS1B, an Immunotherapeutic Target in Uterine and Ovarian Tumors Vinuth Koduru University of Virginia, USA Title : Enhancement of Cell Cycle Inhibition Effect of Cetuximab by Using with Stabilized-Silver Solution in Lung Cancer Cells Aysun Özkan Akdeniz University, Science Faculty, Biology Department, Antalya, Turkey Title : Computer-aided detection of breast masses in mammographic images Omid Rahmani Seryasat Hakim Sabzevari University, Sabzevar, Iran Title : Blocking WNT5A-Interleukin-6-Loop as an Effective Strategy to Impair the Invasive Migration of BRAFInhibitor (BRAFi) Resistant Melanoma Cells Purusottam Mohapatra Skåne University Hospital, Sweden

cancerscience.conferenceseries.com

Speaker Slots Available Title : Evaluation of Protein Induced by Vitamin K Absence, Macrophage Migration Inhibitory Factor and Golgi Protein 73 versus Alpha Fetoprotein for Hepatocellular Carcinoma Diagnosis and surveillance Nahla Ibrahim Cairo University, Egypt Title : Extraction of Breast Cancer Lumps from Mammography Images Using Wavelet Transform and Hidden Markov Model Omid Rahmani Seryasat Hakim Sabzevari University, Sabzevar, Iran Title : Cytotoxic effects of Dichloromethane extract of Basella alba in MCF-7 and MDA-MB-231 breast cancer cells Omowumi Adewale University of Ibadan, Ibadan, Nigeria Title : Nasal cavity tumors in dogs: Minimally invasive electrochemotherapy procedure Felipe Maglietti Universidad de Buenos Aires, Argentina Helena Vasconcelos University of Porto, Portugal

***Poster Presentations*** Title : New opportunities for use of novel, small-molecule PERK inhibitors Wioletta Rozpędek University of Lodz, Poland Title : Novel strategy to cure cancer Adnan Rojeab The London College, U.K Title : Transition metal complexes/organometallic compounds as anticancer/anti HIV drugs or in pharmaceutical industry Anne-France Leclerc University of Liege and University Hospital Centre of Liege, Liege, Belgium Title : Women’s Pursuit in Surpassing Breast Cancer Saint Mikhaiella William Jonas Manila Science High School, Phillipines Title : Pattern of chemotherapy-related adverse effects among adult cancer patients treated at Gondar university referral hospital, Ethiopia: a cross-sectional study

Begashaw Melaku Gebresillassie Gondar University, Ethiopia Title : ExoNet - Intratumor communication network mediated by exosomes in Pancreatic Cancer Carolina Ruivo Instituto de Investigação e inovação em Saúde, Portugal Title : Intercellular communication mediated by exosomes as a new therapeutic target for pancreatic cancer Nuno Bastos, Instituto de Investigação e inovação em Saúde, Portugal Instituto de Investigação e Inovação da Universidade do Porto, Portugal

Title : Breast Cancer of the Youg Woman : Trends Foreseeable with the level of the area of sidi ben abbes- Algeria Messafeur Abdelkrim, University Sidi Bel Abbes - Algeria Title : Assessment of Treatment Compliance and Associated factors among Cervical Cancer Patients in Tikur Anbessa specialized hospital, Oncology unit, Ethiopia 2012 GebreYitayih Abyu Mekelle University, Ethiopia Inês Silva University of Porto, Portugal Diana Sousa University of Porto, Portugal Joana Pereira University of Porto, Portugal

Poster Slots Available

NOTE: Program Schedule is subject to change with final allotment of the speaker slots Contact to Book your Slot ; Mail at [email protected] ; [email protected]

cancerscience.conferenceseries.com

conferenceseries.com

Cancer Science 2017

Conference Highlights • Cancer Cell Biology • Organ Defined Cancers • Cancer Metastasis • Cancer Genetics • Cancer & Tumour Immunology • Cancer : Genomics & Metabolomics • Targeted Cancer Therapy • Stem Cell Therapy • Cancer Biomarkers • Cancer Therapy & Treatment • Alternative Medicine & Cancer • Cancer Case Reports • Novel Approaches to Cancer Therapeutics • Precision Medicine & Cancer Therapy • Cancer Management & Prevention • Cancer Pharmacology

For detailed sessions, please visit: http://[email protected]// Submit your abstract online at: http://[email protected]//abstract-submission.php Register online: http://[email protected]//registration.php

cancerscience.conferenceseries.com

conferenceseries.com

Cancer Science 2017

Glimpses of Cancer Science

cancerscience.conferenceseries.com

conferenceseries.com

Visit the Beautiful City of Lisbon

cancerscience.conferenceseries.com

Cancer Science 2017

conferenceseries.com

12th World Cancer Conference

September 26-28, 2016 London, UK

Scientific Program

Day 1 Registrations

conferenceseries.com

September 26, 2016

Concorde Suite 1&2

Opening Ceremony Keynote Forum

Introduction Title: The decline of the prevalence of cancers during organism senescence Alvaro Macieira-Coelho, French Institute of Health and Medical Research(INSERM), France Title: Early diagnosis of Ovarian carcinoma: Is it possible? Liane Deligdisch, Mount Sinai School of Medicine, USA Networking and Refreshment Break @ Concorde Foyer Title: Maintrac® CTC detection as a tool to uncover the strategies of tumor cells to evade elimination Katharina Pachmann, SIMFO GmbH Bayreuth, Germany Major Sessions: Cancer | Causes and Prevention | Cancer Diagnosis Session Chair: Alain Charest, Harvard Medical School, USA Session Co-Chair: Olivier E Pardo, Imperial College London, UK

Session Introduction Title: The tumor supressor INPP4B functions as an oncogenic regulator in a subset of melanomas Xu Dong Zhang, University of Newcastle, Australia Title: Plasma thermograms-a new approach for cancer biomarker studies Nichola C Garbett, University of Louisville School of Medicine, USA Title: PDGFRα signaling strength confers sensitivity to vinblastine in glioblastoma Alain Charest, Harvard Medical School, USA Title: p53 protects tumor cell survival via a long non-coding RNA under glucose starvation Mian Wu, University of Science & Technology of China, China Title: NRF2-mediated changes in glutathione metabolism mediate the resistance of EGFR-T790M mutant lung cancer cells to erlotinib Olivier E Pardo, Imperial College London, UK Panel Discussion Group Photo Lunch Break Major Sessions: Cancer Therapy | Cancer Drugs | Stem Cell Research Session Chair: Sabine Mai, University of Manitoba, Canada Session Co-Chair: Shahid Gilani, University Hospital of North Midlands, UK Session Introduction

Page 9

Title: A 3D imaging platform to determine the level of genomic instability in cancer Sabine Mai, University of Manitoba, Canada Title: Tumor imaging of small animal by phase contrast X-ray CT technique Thet Thet Lwin, Kitasato University, Japan Title: Circulating epithelial cells; ready for Routine?! Stefan Schuster, SIMFO GmbH Bayreuth, Germany Title: Severe colitis with docetaxel when used in combination with HER-2 receptor blocking antibodies in breast cancer patients Shahid Gilani, University Hospital of North Midlands, UK Title: Lymhoepithelioma-like carcinoma of the uterine cervix– association with Epstein-Barr virus and Human papillomavirus Angel Danchev Yordanov, UMHAT Doctor Georgi Stranski-Pleven, Bulgaria Title: A prospective study of dose escalated image guided radiotherapy and concurrent chemotherapy for esophageal cancers: An evolving standard in developing country setting Srinivas Chilukuri, Yashoda Hospitals, India Networking and Refreshment Break Title: Home based carers’ general knowledge of cancer in a rural village of south africa Takalani Grace Tshitangano, University of Venda, South Africa Title: Trends in the incidence of oral squamous cell carcinoma: A retrospective study Amitha J Lewis, Manipal University, India Panel Discussion September 27, 2016 Day 2

Concorde Suite 2

Keynote Forum

Introduction Title: The role of stem-like glioma cells in GBM progression and post-treatment recurrence Ella L Kim, Johannes Gutenberg University Medical Centre, Germany Perineural invasion in pancreatic cancer Qingyong Ma, Xi’an Jiaotong University, China Networking and Refreshment Break Major Sessions: Organ Specific Cancers Session Chair: Javier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico Session Co-Chair: Ciro Roberto Rinaldi, University of Lincoln, UK Session Introduction Title: Mechanism of Action of G-quadruplex forming oligonucleotide homologous to the telomere overhang in melanoma Neelu Puri, University of Illinois College of Medicine at Rockford, USA Title: PU.1 Expression correlates with patient disease status in the myelodysplatic syndromes, a new prognostic marker Ciro Roberto Rinaldi, University of Lincoln, UK Title: The combination astemizole-gefitinib as a novel and promising therapy for human lung cancer: In vitro studies Javier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico Title: Near infrared transillumination detection of prostate carcinoma in vitro Besarion Partsvania, Georgian Technical University, Georgia Title: Heightened state of oxidative stress in MCF-7 cells enhances growth potential and promotes EMT by increasing Akt and ERK activity Milad Bitar, Kuwait University, Kuwait Title: Desmoplasia suppression by Metformin-mediated AMPK activation inhibits pancreatic cancer progression Qingyong Ma, Xi'an Jiaotong University, China Title: Cytocidal effects of active bufadienolides on human cancer cells and its possibility of enhancing host immunity as an adjuvant therapeutic reagent Bo Yuan, Tokyo University of Pharmacy and Life Sciences, Japan Lunch Break Young Researchers Forum Page 10

Title: Diet and colorectal cancer: Black raspberries prolong life Stephanie May, Cardiff University, UK Title: BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas & a mycotic aortic aneurysm David M Smith, St James’ University Hospital, UK Title: H3K4-specific histone methytranferase MLL3 regulates EMT in pancreatic cancer cells Chenyi Liu, University of Toronto, Canada Title: Prodigiosin associated anti metastatic effect and induction of apoptosis in adeno gastric carcinoma N Darshan, Central Food Technological Research Institute, India Title: frequent v600e & other non-hotspot braf mutations in adult differentiated thyroid cancer Murugan Avaniyapuram Kannan, King Faisal Specialist Hospital & Research Center, KSA Title: Association of proline allele at codon 72 of TP53 gene with triple negative breast cancer (TNBC) in females from North Eastern Region, India Kaustab Mukherjee, Regional Medical Research Centre-Dibrugarh, ICMR, India Title: Toxin-based targeted therapeutics for the treatment of solid tumors Stefania Zuppone, San Raffaele Scientific Institute, Italy Networking and Refreshment Break Poster Presentations 16:10-18:00 @ Concorde Foyer September 28, 2016 Day 3

Meeting Room 9

Major Sessions: Oncology and Cancer | Cancer Treatment and Therapeutics|Alternative Medicine and Cancer | Radiation Oncology Session Chair: Jiri Vachtenheim, Charles University in Prague, Czech Republic Session Introduction Title: GLI2, a Hedgehog signaling pathway effector, is a transcription activator of survivin expression in human tumor cells Jiri Vachtenheim, Charles University in Prague, Czech Republic Title: psiTPTE22-HERV functions as a tumor suppressor and is epigenetically down-regulated in gastric cancer Jessie Qiaoyi Liang, The Chinese University of Hong Kong, China Networking and Refreshment Break 10:40-11:00 @ Concorde Foyer Title: Pathological diagnosis and workup of lung cancer in the middle east and north africa: patterns and challenges Mohammed Al Hajjaj, University of Sharjah, UAE Title: Bamboo shoot consumption lowers the risk of breast cancer: A case-control study from North East Region, India K Rekha Devi, Regional Medical Research Centre-Dibrugarh, ICMR, India Title: Anaemia in cancer patients undergoing radiotherapy: Our experience at the National Hospital Abuja, Nigeria Chinedu S Aruah, National Hospital Abuja, Nigeria Title: The anti-cancer effect of methanolic extract of Pistacia lentiscus MEPL in human ovarian cancer cells Imane Charid, University Abderrahmane Mira, Algeria Title: Prosopis juliflora lleaves extract induces apoptosis in the breast cancer cells Raju N Gacche, Swami Ramanand Teerth Marathwada University, India Video Presentation Lunch Break 13:00-13:40 @ Aromi Restaurant Thanks Giving & Closing Ceremony

Bookmark your dates

19th World Cancer Conference

October 23-25, 2017 Milan, Italy

e-mail: [email protected]; [email protected] Website: www.cancer.global-summit.com/europe Page 11

conferenceseries.com 538th Conference

Scientific Program

10th Global Annual Oncologists Meeting July 11-13, 2016

Cologne, Germany

Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1 702 508 5200 Ext: 8033 e-mail: [email protected]; [email protected]

Registrations

Day 1

July 11, 2016

Amsterdam conferenceseries.com

Opening Ceremony Keynote Forum

Introduction Sensitivity and specificity of the empirical Lymphocyte Genome Sensitivity (LGS) assay: Implications for improving cancer diagnostics Diana Anderson, University of Bradford, UK Optimizing HER2 assessment in breast cancer - Application of automated image analysis Martin Kristensson, Visiopharm, Denmark Networking & Refreshment Break Session Introduction

Session 1: Oncology & Organ Specific Cancer Session Chair: Ajay Singh, Mitchell Cancer Institute, USA Session Co-Chair: Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, Germany Understanding and overcoming chemoresistance of pancreatic cancer Ajay Singh, Mitchell Cancer Institute, USA Patent protection for diagnostics and therapeutics - The essentials and importance of second medical use patents in precision medicine Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, Germany The chemopreventive potential of silver nanoparticles against UVB-induced skin carcinogenesis Seema Singh, Mitchell Cancer Institute, USA VP: Perioperative use of NSAID might prevent early relapses in breast and other cancers: An upstream approach Michael Retsky, Harvard TH Chan School of Public Health, USA Group Photo 12:50-13:00 Lunch Break Human borna disease virus infection impacts host proteome and histone lysine acetylation in human oligodendroglia cells Xia Liu, Institute of Forensic Science, China Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine Yan-Shen Shan, Cheng Kung University, Taiwan Evaluation of actionable mutation (KRAS, BRAF and PIK3CA) in colon cancer: Determination of frequency, distribution pattern in Indian patients B R Das, Research and Development, SRL Ltd., India Challenges in treating Ca Nasopharynx, Ca Tonsil and post op Head neck cancers by Intensity Modulated Radiationtherapy Anitha Gopal, Fortis hospitals, India One-step mixing with anti-tumor/anti-CD3 bispecific antibody enhances tumor targeting and therapeutic efficacy of ex vivo expanded T cells Kuo-Hsiang Chuang, Taipei Medical University, Taiwan Networking & Refreshment Break Dendritic cell vaccine therapy in breast cancer patients Yathish Kumar, Karnataka cancer hopsital & research centre, India Revisiting the value and role of anti-angiogenesis in solid tumors and the mechanism to inhibit angiogenesis, and their possible complications: Pediatric oncologists view. Mahdi Shahriari, Shiraz University of Medical Sciences, Iran Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan Muhammad U Rashid, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan

Page 13

Day 2

July 12, 2016

Amsterdam

Keynote Forum Introduction Isolated Thoracic Perfusion with Chemofiltration (ITP-F) breaks through drug resistance in progressive and pretreated malignant pleural mesothelioma Karl R Aigner, Medias Klinikum GmbH & Co KG, Germany New method of quantitative, circulating tumor cell (CTC) diagnostic, treatment selection, monitoring and surveillance with superior outcome for the patient Matin Burrow, DMB-Diagnostics GmbH, Germany Networking & Refreshment Break Session 2: Cancer Causes, Cancer Diagnostics, Cancer Treatment and Therapy & Clinical Oncology Session Introduction Session Chair: Diana Anderson, University of Bradford, UK Session Co-Chair: Apollon Karseladze, N. Blokhin Cancer Research Center, Russian Federation General overview of the Comet assay Diana Anderson, University of Bradford, UK The march of pathologists into ‘Big Industry’ or the worries of a newly transformed surgical pathologist Diana Stanoeva, Histogenex, Belgium Impairment of vascularization of the surface covering epithelium induces ischemia and promotes malignization: A new hypothesis of a possible mechanism of cancer pathogenesis Apollon Karseladze, N. Blokhin Cancer Research Center, Russian Federation Cholesterol Import and steroidogenesis are Biosignatures for gastric cancer progression Wen-Lung Ma, China Medical University Hospital, Taiwan Lunch Break Poster Presentation Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma Magalie Tardy, Centre Antoine Lacassagne, France The fetal risks from diagnostic use of radiation during pregnancy: A systematic review and proposal of a clinical protocol Mafalda Sofia Barros Gomes, Centro Hospitalar do Porto, Portugal Prognostic factors and their correlation with staging in patients with Multiple Myeloma: A single centre study in North India Tanvi Sood, Shri Ram Murti Smarak Institute of Medical Sciences, India VP: MicroRNA-21 expression in primary breast cancer tissue among female patients and its correlation with chromosome 17 aneusomy Noura Ramadan, Suez Canal University, Egypt Combined bevacizumab and stereotactic radiosurgery for the treatment of a child with recurrent medulloblastoma Ming Zhao, Chinese PLA General Hospital, China Keynote Forum Keynote Presenation by Hirendra Nath Banerjee Elizabeth City State University, USA Networking & Refreshment Break Award Ceremony Day 3 July 13, 2016 Extended Networking Session & Lunch

Bookmark your dates

16th Global Annual Oncologists Meeting

April 24-25, 2017 Dubai, UAE

e-mail: [email protected] web: annualmeeting.conferenceseries.com/oncologists/ Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-888-843-8169 Fax: +1-650-618-1417 [email protected]

Conference Series Ltd Heathrow Stockley Park Lakeside House, 1 Furzeground Way Heathrow, UB11 1BD United Kingdom [email protected]

OMICS International 6th Floor, North Block Divyasree Building, Raidurg Hyderabad Telangana, INDIA-500032 Tel: +91-40-33432300 [email protected]

Toll free USA & Canada: +1-800-216-6499 Australia: +1-800-651-097 Europe: 0805-080048 Page 14

conferenceseries.com

Scientific Program

Cancer Diagnostics Conference & Expo June 13-15, 2016

Rome, Italy

Hosting Organization: Conference Series LLC

2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-702-508-5200 Ext: 8047, Toll free: +1-800-216-6499 e-mail: [email protected]; [email protected] Page 15

Scientific Program Day 1

June 13, 2016

Registrations

Olimpica-4

conferenceseries.com

Opening Ceremony Keynote Forum

Introduction Title: Sensitivity and Specificity of the Empirical Lymphocyte Genome Sensitivity (LGS) Assay: Implications for Improving Cancer Diagnostics

Diana Anderson, University of Bradford, UK Title: Optimal Breast Cancer Pathology 2016

Tibor Tot, Centarl Hospital Falun, Sweden Group Photo Networking & Refreshments Break Track 1: Cancer Diagnostics Market Track 2: Cancer Diagnostics Types

Session Introduction

Session Chair: Diana Anderson, University of Bradford, UK Session Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: Fast Evaluation of Biopsy for Prostate Cancer Diagnosis by Fraunhofer IKTS Andreas Lehmann, Fraunhofer Institute for Ceramic Technologies and Systems IKTS, Germany Title: How to develop a cancer diagnostic device for the POC setting Juan Roman, Cambridge Consultants, UK Title: Engineering design process and comparison of multi wavelength real time auto-fluorescence and fluorescence imaging guide system irradiance with xenon lamps and light-emitting diodes (LEDs) for open and laparoscopic cancer surgery Hyun Soo lim, Chungnam National University, South Korea Title: Development of female vaginal fluid collection device for the endometrial cancer preliminary study Jhih-Yan Cheng, National Tsing Hua University, Taiwan Lunch Break Track 7: Predictive Cancer Biomarkers Track 9: Cancer Treatment Session Introduction Session Chair: Diana Anderson, University of Bradford, UK Session Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: The role of pancreatic stellate cells in pancreatic disorders Oleg V Gerasimenko, Cardiff University, UK Title: Differences of signalling pathways and miRNA expression in colon and breast carcinoma cell lines on hipoxic condition Hafize Seda Vatansever, Celal Bayar University, Turkey Title: The role of Epo/EpoR signaling pathway in colorectal cancer Renata Dobrila Dintinjana, Clinical Hospital Center Rijeka, Croatia Title:Fertility sparing surgery in early stages of cervical cancer Aleksandar Stefanović, President M.D. Ph. D UGOSCGRS, Belgrade Title: Fertility sparing in young patients with early stages of endometrial cancer Katarina Jeremic, University of Belgrade School of Medicine, Serbia Networking & Refreshments Break

Page 16

Title: Anticancer activities of religiously important plants from India Rachana, Jaypee Institue of Information Technology, India Title: Prostatic tissue levels of chemical elements as cancer markers Vladimir Zaichick, Medical Radiological Research Center, Russia Special Session Title: Breast Cancer Heterogenity Tibor Tot, Central Hospital Falun, Sweden Title: General Overview of the Comet assay Diana Anderson, University of Bradford, UK Day 2 June 14, 2016

Olimpica-4

Keynote Talk Title: The UHRF1 expression in serum and tissue for gastric cancer detection Feng Yan, Nanjing Medical University and Jiangsu Cancer Hospital, China

Track 3: Cancer Screening Tests Track 6: Approaches in Cancer Therapy Track 8: Cancer Genomics and Epigenetics Track 10: Recent Diagnostics Technologies

Session Introduction Session Chair: Feng yan, Nanjing Medical University and Jiangsu Cancer Hospital, China Session Co-Chair: Senqing Chen, Nanjing Medical University and Jiangsu Cancer Hospital, China Title: Serum biomarkers and ovarian cancer risk: Utility for early detection and prevention Dayan Goodenowe, President, Phenomenome Discoveries Inc., Canada Title: Molecular basis of hereditary colorectal cancer and current research status Chen Senqing, Jiangsu Institute of Cancer Research, China Networking & Refreshments Break Title: The mechanisms of asparaginase-induced pancreatitis Julia V Gerasimenko, Cardiff University, UK Title: Tumor-derived exosomes in cancer progression and treatment failure Shaorong Yu, Jiangsu Institute of Cancer Research, China Title: Mast cells inhibition as therapeutic approach on mammary cancer Ana I Faustino-Rocha, University of Trás-os-Montes and Alto Douro, Portugal Poster Presentations CDE001 Title: Prognostic significance of N-glycolyl GM3 ganglioside expression in non-small cell lung carcinoma patients: New evidences Adriana Carr Perez, Center of Molecular Immunology, Cuba Title: A functional approach for searching biomarkers of glioma CDE002 Kopylov Alexey, Lomonosov Moscow State University, Russia Title: Molecular study of synthesis of protoporphyrin IX in fluoropositive and fluoronegative CDE003 cell cultures of human glioblastoma Pavlova Galina, Institute of Gene Biology-RAS, Russia Title: Renal cell carcinoma in kidney transplant candidates CDE004 Konstantinos A Zorbas, Temple University Hospital, USA Title: Frequent ID4 gene promoter hypermethylation in breast cancer CDE005 Yan Zhang, Jiangsu Cancer Hospital, China Title: Asymmetrical asymptomatic tonsils CDE006 Joseph Colclough, Northwick Park Hospital, UK Title: New ruthenium phthalocyanines in modulation of nitric oxide and singlet oxygen CDE007 release: Physical chemical characterizations and improvement of cytotoxicity with liposomes against cancer cells Ramos L.C.B, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Brazil Title: The role of FABP9 in prostate cancer CDE008 Majed Al Fayi, Liverpool University, UK Title: Experimental treatment of prostate cancer by suppressing the biological activity of FABP5 CDE009 Waseem Al-Jameel, University of Liverpool, UK Title: Improving Breast Cancer diagnosis by circulating microRNAs CDE010 Julia Alejandra Pezuk, Instituto Sirio-Libanes de Ensino e Pesquisa – Hospital Sirio-Libanes- Sao Pablo, Brazil Lunch Break Page 17

Title: Comparison of the MRI sequences in ideal fiducial marker-based radiotherapy for prostate cancer Osamu Tanaka, Gifu Municipal Hospital, Japan Title: Monitoring cancer progression by detecting circulating cancer cells with both epithelial and mesenchymal features Yong-Jie Lu, Queen Mary University of London, London, UK Title: The status of medicinal plants and herbal drugs in prevention and treatment of cancer Majid Asadi-Samani, Shahrekord University of Medical Sciences, Iran Title: Probable non-papillomavirus etiology of warty carcinoma of the uterine cervix Dimitrova B, Medical University Pleven, Bulgaria Title: The possible involvement of Epstein–Barr virus in the etiology of leukemia in Sudanese patients Haitham Eltigani Mohammed Elawad, Omdurman Islamic University, Sudan Networking & Refreshments Break Title: Combination Therapy against NGcGM3 ganglioside and EGFR: A new approach for lung cancer treatment. Adriana Carr Perez, Center of Molecular Immunology,Cuba Title: Evaluation of the SYT-SSX2 fusion gene transcript in synovial sarcoma cells and microvesicles as a potential biomarker for synovial sarcoma Fricke Alba, University of Freiburg, Germany Panel Discussions Award & Closing Ceremony Day 3

June 15, 2016 Networking and Lunch @ 12.00-13:00 @ Restaurant

Bookmark your dates

2nd Cancer Diagnostics Conference and Expo May 08-10, 2017 Dubai, UAE E-mail: [email protected] Website: cancerdiagnostics.conferenceseries.com/ Conference Series 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-888-843-8169 Fax: +1-650-618-1417 [email protected]

Conference Series 5716 Corsa Ave., Suite 110, Westlake Los Angeles, CA 91362-7354, USA Ph: +1-650-268-9744 Fax: +1-650-618-1414 [email protected]

Conference Series SEZ Unit, Building No. 20, 9th Floor APIIC Layout, HiTec City Hyderabad-500081, Telangana, INDIA Ph: 040-40131823, 040-47482222 [email protected]

Toll free USA & Canada: +1-800-216-6499 Australia: +1-800-651-097 Europe: 0805-080048

Page 18

389th OMICS International Conference

Scientific Program 5th World Congress on

cancersummit.org

Cancer Therapy September 28-30, 2015

Atlanta, USA

Exhibitor

OMICS International Conferences

2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA Phone: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499 Toll free: +1-800-216-6499, Email: [email protected]

Scientific Program Day 1 September 28, 2015 Registrations

Chattahoochee Salon C

Opening Ceremony Keynote Forum Introduction A review of cancer immunotherapies and nutritional therapies Jack C. Westman, University of Wisconsin School of Medicine & Public Health, USA

BAI1 is a brain-specific tumor suppressor Erwin G. Van Meir, Winship Cancer Institute, Emory University, USA

New simple method of detecting various cancers & their biochemical information from rapidly changing part of QRS complex of ECGs and its clinical application for screening and evaluation of cancer Yoshiaki Omura, New York Medical College, USA

Systemic and interstitial photodynamic laser therapy: New options in oncology Michael Weber, Weber Medical, Germany Coffee Break

Chemoprevention of experimental mammary carcinoma by Trianthe ma portulacastrum Linn., an Indian dietary and medicinal plant Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA Scientific Sessions: Cancer Cell Biology, Diagnosis & Applied Research Organ-Specific Cancer Advances in Malignancy Counteractive Action and Screening Session Chair: Yoshiaki Omura, New York Medical College, USA Session Chair: Fereydoon Family, Emory University, USA Session Introduction Non- Invasive, quick, simple diagnostic method and safe, effective, individualized treatment of various cancers without side effects Yoshiaki Omura, New York Medical College, USA Identification of Quinones as growth inhibitors of Trastuzumab resistant breast cancer cells Jayalakshmi Sridhar, Xavier University of Louisiana, USA Higher grade Gliomas have more diffused invasive fronts: Quantitative histology analysis of IDH1+ Gliomas Fereydoon Family, Emory University, USA Exosomes in the treatment of pancreatic adenocarcinoma Horacio Rilo, North Shore LIJ Health Systems, Hofstra University, USA Hepatocellular carcinoma screening in Cirrhosis: Inappropriate use of CT / MRI scan Ashwani K. Singal, University of Alabama, USA Group Photo Lunch Break

Page 20

Atypical PKC signaling and breast cancer metastasis Soumen Paul, University of Kansas Medical Center, USA Anti-Cancer preparation NSC 631570 Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria Target genes for acidosis-dependent anti-cancer drugs Hiroshi Kobayashi, Chiba University, Japan Controlling Ras stability via the Wnt/β-catein signaling: Implication in cancer therapy Kang-Yell Choi, Yonsei University, Korea Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKa and ERK1/2 signaling pathways in human non-small cell lung cancer cells Swei Sunny Hann, University of Guangzhou Traditional Chinese Medicine, China RelB-mediated EMT activation promotesbone metastasis of prostate cancer Yong Xu, Nanjing Medical University, China Hypermethylation of P15, P16, and E-cadherin genes in ovarian cancer Taha A. Kumosani, King Abdulaziz University, Saudi Arabia UV light analisys of anticancer drug NSC 631570 in urine samples sorts healthy donors and prostate adenocarcinoma patients. Could the different drug up-take used to establish free-diagnosis cancer patients? Larysa M. Skivka, ESC “Institute of Biology”, Taras Shevchenko National University, Ukraine Coffee Break The relevance of the cytological diagnostic in the mamary gland cancer Ciobica Alin, Alexandru Ioan Cuza University, Romania Effect of dietary fatty acids on development of carcinogen-induced breast cancer in female fisher (F344) rats Surekha MV, National Institute of Nutrition, India Sprague Dawley/NIN hairless mutant rat–A model to study carcinogenesis? M. SatyaVani, National Institute of Nutrition, India Chemopreventive effects of ginger Nirmala Kota, National Institute of Nutrition, India Sesame lignans: Potent components as nutraceuticals/functional foods Hemalatha Sanagaram, National Institute of Nutrition, India Clinical characterization of patients with diagnosis of lung cancer in Joaquin Albarran´s Teaching Hospital Joan Fabian Fernandez de la Vega, General Calixto Garcia´s Teaching Hospital, Cuba The EGFR- targeted chimeric antigen receptor- modified T cells immunotherapy for patients with EGFR- expressing advanced or relapsed/refractory solid tumors Weidong Han, The General Hospital of PLA, China Context specific role of deubiquitylase enzyme, USP9X in oral squamous cell carcinoma Devathri Nanayakkara, Griffith University, Australia Day 2 September 29, 2015

Chattahoochee Salon C Scientific Sessions: Anti Cancer Drugs & Delivery Novel Approaches to Cancer Therapeutics Cancer Therapy Clinical Cancer Research Cancer & Lifestyle Connection Complementary & Alternative Medicine (CAM) Cancer Biomarkers Cancer Nanotechnology Session Chairs: Yoshiaki Omura, New York Medical College, USA Sherri Z. Millis, Advanced Individual Medicine, USA Session Introduction

Page 21

Molecular engineering of Fc fusion proteins to tailor effector function to clinical indication Steven Chamow, Chamow & Associates Inc., USA Cancer cell- state plasticity and resistance to therapy Raffaella Sordella, Cold Spring Harbor Laboratory, USA Development of protein agent targeting Integrins αvβ3 at a novel site by rational protein design Zhi-Ren Liu, Georgia State University, USA Hyaluronic Acid (HA) drug conjugates for targeted delivery of anticancer drugs: CA102N, A novel Hyaluronic acid conjugated drug against colorectal cancer Eskouhie Tchaparian, Holy Stone Healthcare Co., Ltd., Taiwan Different uptake of Ukrain can explain the selective effect against pancreatic adenocarcinoma cell cultures in vitro Niccola Funel, University of Pisa, Italy A persulfide analog of the nitrosothiol SNAP, D-P*, induces apoptotic cell death in Jurkat leukemia T-cells Burkhard Kloesch, Ludwig Boltzmann Institute for Rheumatology, Austria Coffee Break Alkoxyamines for the in-situ generation of radicals as theranostic agents Paul Bremond, Aix-Marseille University, France Tyrosine Isomers mediate the classical phenomenon of concomitant tumor resistance and exhibit a powerful antimetastatic effect with undetectable toxic-side effects Raul A. Ruggiero, National Academy of Medicine, IMEX-CONICET, Argentina Synthesis and preliminary mechanistic evaluation of N-(Substituted-1,3-Benzothiazol-2-yl)-2-(4-SubstitutedPiperazin-1-yl) Acetamide derivatives with potent antiproliferative activity on human cancer cell lines Mine Yarim, Yeditepe University, Turkey Anti-tumor activity of Wei-Shen: Pre- Clinical and clinical studies Yuguo Yu, Jiangsu Andeson Biomedical Inc., China Gold nanorods-incorporated mesoporous magnetic nanoparticles for targeted drug delivery and near-infrared photothermal therapy in cancer Hung-Wei Yang, National Sun Yat-sen University, Taiwan Assessment of the stemness-suppressive effects of several SHP-1 activators in human colorectal cancer cells Yeu Su, National Yang-Ming University, Taiwan Modulated electro-hyperthermia: A local treatment may evoke distant anti-tumor response in a mice double colorectal allograft model Tamas Vancsik, Semmelweis University, Hungary Lunch Break Profiling cancer gene mutations in non-small cell lung cancer by droplet digital PCR Dongqi Tang, The Second Hospital of Shandong University, China Assessment and treatment of cancer pain: Our experience in Serbia Gvozdenovic Ljiljana, Clinical Center of Vojvodina, Serbia Nanotubes and their functions in cancer H. Seda Vatansever, Celal Bayar University, Turkey Implications for antimicrobial, anticancer activity and molecular docking studies of N4-Tetradentate Tin macrocycles Ekta Rawat, Kurukshetra University, India Development and preclinical testing of protein-based curcumin delivery forms for control of cancer Lissy Krishnan, Sree Chitra Tirunal Institute for Medical Sciences and Technology, India Bioengineered Fusokine GIFT4 for cancer immunotherapy Jiusheng Deng, Emory University School of Medicine, USA Monoclonal antibodies that target pancreatic and colorectal cancer for both diagnosis and therapy Myron Arlen, North Shore University Hospital, USA Coffee Break

Page 22

C and 1H NMR metabolic markers of therapeutic response upon signal transduction inhibitors in lymphoma cells and in vivo Seung-Cheol Lee, University of Pennsylvania, USA Next generation sequencing methodologies in identifying biomarkers and treatment options across cancers Sherri Z. Millis, Advanced Individual Medicine, USA The effects of animal- assisted interventions (AAIs) for pediatric oncology patients and their parents at five hospital sites Amy McCullough, American Humane Association, USA Alterations in actin binding proteins and miR~17-92 cluster in cancer cell metastasis and attenuation by DHA Mehboob Ali, The Research Institute at Nationwide Children’s Hospital, USA Cytoreductive surgery and HIPEC for peritoneal carcinomatosis of a gallbladder carcinoma Elke Wagler, Department of General, Visceral and Oncosurgery, Pleißental-Klink Werdau, Germany Supporting the survivors: Cancer fatigue syndome and cancer rehabilitation Naomi Dolgoy, University of Alberta, Canada Combining ultrasound and nanoparticle for cancer treatment Chung-Hsuan (Winston) Chen, Genomics Research Center, Academia Sinica, Taiwan 13

Day 3 September 30, 2015

Chattahoochee Salon C Scientific Sessions: Cancer Chemotherapy Pediatric Oncology Anti-Cancer Agents in Medicinal Chemistry Session Chairs: Michael Weber, Weber Medical, Germany Deniz Peker, University of Alabama, USA Session Introduction A unique case of synchronous extramedullary spinal masses-is surgery an answer? Rachana Yendala, University of Toledo Medical Centre, USA Feasibility assessment foroncology trials Maxim Belotserkovskiy, Global Head Medical Affairs at PSI CRO AG, Switzerland Identifying the border of cutaneous squamous cell carcinoma by targeted EGFR antibodies conjugated to gold nanoparticles Asaf Olshinka, Rabin Medical Center, Israel The presence of aflatoxin B1-FAPY adduct and Human Papilloma Virus in cervical smears from cancer patients in Mexico Magda Carvajal, National Autonomous University of Mexico, Ciudad Universitaria, Mexico Cytotoxyc effect of Solanum rastratum dunal (mexican thisle) on cervical cancer cells (Siha) Maria Del Carmen Valadez Vega, Instituto de Ciencias de la Salud, Mexico Polymorphisms in one- carbon metabolism pathway affect survival of Chinese resected gastric cancer patients Jinfei Chen, Nanjing First Hospital, China Coffee Break Analysis of APOBEC3 and driver genes polymorphisms in Moroccan patients with breast cancer Chaymaa Marouf, University Hassan II Ain Chock, Morocco Estimating the total cost of cancer management: A descriptive prospective Cohort study among patients with cervical cancer at Ocean Road Cancer Institute, Dar es Salaam, Tanzania Harrison R. Chuwa, Ocean Road Cancer Institute (ORCI), Tanzania First inhibitors of the human mitotic Kinesin MKLP-2 synthesis, biological evaluation and structure-activity relationships Catherine Guillou, Gif Research Center, CNRS, LabEx, France Recognizing paediatric brain tumours in the emergency department Babakhanlou R, University of Edinburgh, Scotland Design, synthesis and antiproliferative activity of 6-substituted Pyridazin- 3(2H)-ones Mohamed Elagawany, Damanhour University, Egypt Cancer therapy, a review on anti neoplastic agent Juhi Tiwari, Jayoti Vidyapeeth Women’s University, India Secondary malignancies as long term adverse effects of chemo- and radiation therapy Deniz Peker, University of Alabama, USA Lunch Break Workshop on Page 23

The practical applications of lasers for photodynamic cancer therapy Michael Weber, Weber Medical, Germany The Frequency of nucleophosmin1 gene mutation in newly diagnosed patients of acute myeloid leukaemia Muhammad Ayyub, Armed Forces Institute of Pathology, Pakistan Association between GSTP1 genotypes and hormone receptors phenotype in invasive ductal carcinomas of breast Marwan A. Bakarman, King Abdulaziz University, Saudi Arabia Resveratrol gold nanoparticles: Synthesis, characterization and in-vitro anticancer activity Shrinivas Bumrela, Sinhgad Institute of Pharmaceutical Sciences, India Toxicological evaluation of anticancer α- Eleostearic acid rich fat extracted from seeds of bitter melon (Momordicacharantia) using a mouse model K.N.K. Ranasinghe, University of Peradeniya, Sri Lanka First-in-class GnRH analog for cancer therapy Gregory Lee, University of British Columbia, Canada Coffee Break Inhibition of multidrug resistance protein I (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme Tivnan A., Royal College of Surgeons in Ireland, Ireland SUMOylation: A link to future therapeutics Faheem Ahmed Khan, Huazhong Agricultural University, China S.I.M.P.L.E.™ permanent hair removal as an option for unwanted hair growth experienced as a side-effect of cancer treatment drugs Suzanne Anderer, Illinois School of Electrology, USA Fertility of female lymphoma patients treated with chemotherapy Helen Gharwan, Sinai Hospital of Baltimore, USA TRB2-SKP2 signaling and SKP2 targeted therapy in human retinoblastoma and related tumors Xiaoliang X. Xu, Zhongshan University, China Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors Xia Xi, Peking University Shenzhen Hospital, China Award Ceremony

CTPO01 CTPO02 CTPO03 CTPO04 CTPO05 CTPO06 CTPO07 CTPO08 CTPO09

Poster Session Prevalence of cell-free DNA mutations in patients with renal cell carcinoma: Preliminary findings Christopher Keith, Emory University School of Medicine, USA Bacterial MazF mediated apoptosis in colorectal adenocarcinoma HT29 cells Maryam Saffarian, Clemson University, USA G-quadruplex formation in the kRAS mid promoter region and identification of stabilizing small molecules as promising transcriptional silencers Rhianna K Morgan, University of Mississippi, USA Potentiating of human papilloma vaccine candidate using Naloxone/Alum mixture as adjuvant: Increase of the immunogenicity and polarization to Th-17 Mahsa Yasaghi, Islamic Azad University of Pharmaceutical Science, Iran Adherence to postmastectomy radiation therapyamong N2/N3 female breast cancer in Taiwan and its associated predicting factors: a national wide retrospective population-based study Zhen-Ying Liu, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan Synthesis of functional liposomes for targeted chemotherapy and photodynamic therapy in brain tumor Chih-Wen Lin, National Tsing Hua University, Taiwan Mesoporous nanoparticles-incorporated temperature-sensitive hydrogel for controlled drug/gene delivery in brain tumor Feng-Wei Lin, National Sun Yat-sen University, Taiwan Hypodermic drug delivery for androgen inhibition using dissolving microneedle patches in prostate cancer therapy Jing-Fong Liao, National Sun Yat-sen University, Taiwan Immunomodulatory molecules in glioblastoma multiforme tissues and primary cells Shao-Chih Chiu, China Medical University, Taiwan Page 24

CTPO10 CTPO11

e-CTPO01 e-CTPO02 e-CTPO03 e-CTPO04 e-CTPO05 e-CTPO06 e-CTPO07 e-CTPO08 e-CTPO09 e-CTPO010 e-CTPO011

Status of GSTP1 homozygous variant allele (Val/Val) genotype and susceptibility to colorectal cancer in Saudi Arabia Marwan A. Bakarman, King Abdulaziz University, K. Saudi Arabia Pharmaco-dynamic of peptide HM-3 and its effect on HCT-116 tumor micro-environment Sitelbanat Sitelbanat Yassin, China Pharmaceutical University, China e-posters What kinase gene expressed differently in primary and metastatic kidney cancer Amy Zhao, University of Alabama, USA Morphofunctional inactivation of Jurkat T-cells by the titanium oxides coating Khlusov I A, Siberian State Medical University, Russia Synthesis and apoptotic potential establishment of 1,2-oxaphospholes Dobromir D Enchev, Konstantin PreslavskyUniversity, Bulgaria Molecular interaction studies of Anthraquinone derivatives, potent anticancer agents from the root of Morinda Citrifolia (Noni) Shine. D., D. Y. Patil University, India The relevance of some molecular markers in recurrent pancreatic cancer: Focusing on CA 19-9 and cytokeratins Alin Ciobica, Alexandru Ioan Cuza University, Romania The importance of clinical and instrumental diagnostic in the mamary gland cancer Alin Ciobica, Alexandru Ioan Cuza University, Romania Studying the post-operatory and molecular modifications in the chronic pancreatitis and pancreatic cancer: Micronutrients and pancreatic enzyme supplementation Alin Ciobica, Alexandru Ioan Cuza University, Romania A study regarding the quality of life evaluation in patients with terminal pancreatic cancer Alin Ciobica, Alexandru Ioan Cuza University, Romania Psychological and psychiatric manifestations in patients with cancer Alin Ciobica, Alexandru Ioan Cuza University, Romania Understanding tumoral markers in patients with pancreatic cancer Alin Ciobica, Alexandru Ioan Cuza University, Romania Working with paradoxes: Moving from dialectical opposition to interdependent growth in culturally diverse female cancer survivors Kirti Patel, Sofia University, USA Closing Ceremony

Bookmark your dates

14th World Congress on

CancerDecember Therapy 08-10, 2016 Baltimore, USA

OMICS International 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-888-843-8169 Fax: +1-650-618-1417 [email protected]

OMICS International 5716 Corsa Ave., Suite 110, Westlake Los Angeles, CA 91362-7354, USA Ph: +1-650-268-9744 Fax: +1-650-618-1414 [email protected]

OMICS Group SEZ Unit, Building No. 20, 9th Floor APIIC Layout, HITEC City Hyderabad-500081, Telangana, INDIA Ph: 040-40131823, 040-47482222 [email protected]

Toll free USA & Canada: +1-800-216-6499 Australia: +1-800-651-097 Europe: 0805-080048 Page 25